Actor Danny Glover Takes on New Role to Fight Anemia

Philadelphia, PA (March 1, 2002) - Actor Danny Glover, best known for his role in the Lethal Weapon movies and currently starring in the recently-released hit, The Royal Tenenbaums, will be launching his latest project today—not on the big screen, but in the fight against anemia.

Glover will make an appearance at the National Kidney Foundation's (NKF) Executive Leadership Conference today at the Loews Philadelphia Hotel to announce his new role as spokesperson for the Foundation's "Kidney Walks" and to pledge his support to Anemia LifeLine™—a program designed to increase awareness of the signs and symptoms of anemia associated with serious conditions. Anemia LifeLine™ will provide information and educational materials about anemia to patients, caregivers and healthcare professionals and is a project created by Amgen in collaboration with the National Kidney Foundation, The Wellness Community and the National Anemia Action Council (NAAC).

Anemia occurs when the body does not produce enough red blood cells to carry oxygen to the body's organs and tissues. Anemia associated with serious diseases can cause significant fatigue, weakness and can even damage the heart. It may be difficult to identify because early symptoms may be mild and similar to those of a serious disease or medication side effects.

Glover knows first-hand the impact anemia associated with serious diseases can have. His father, James, suffered from anemia associated with chronic kidney disease which completely deprived him of energy until he was diagnosed and treated for his condition.

Throughout 2002, Danny will appear in various LifeLine™ education materials including a public service announcement, a patient brochure and "What's Your AQ™?" a quiz designed to help people talk to their doctors about anemia symptoms. Danny will also be appearing at several NKF "Kidney Walks" across the country.

The National Kidney Foundation is dedicated to preventing kidney and urinary tract disease, improving the health and well-being of individuals and families affected by these diseases and increasing the availability of all organs for transplantation.